PHARMA MAR, S.A. «...161718» Page 16 out of 18 03/06/2020 08:29 PHARMA MAR, S.A. On business and financial situation The Company announces that the Therapeutic Goods Administration (TGA) has granted the “Provisional Approval Pathway” for lurbinectedin in relapsed Small Cell Lung Cancer in Australia. Register number: 2543 27/05/2020 17:38 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 20 May and 26 May 2020. Register number: 2453 20/05/2020 17:35 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 13 May and 19 May 2020. Register number: 2324 14/05/2020 20:09 PHARMA MAR, S.A. Announcement of general shareholders’ meeting The communication with registration number 2256 is rectified by attaching the announcement of the General Meeting of Pharma Mar, S.A. Register number: 2264 Notification modified by communication number 2256 dated 14/05/2020 (18:10) 14/05/2020 18:10 PHARMA MAR, S.A. Announcement of general shareholders’ meeting The Company sends notice of call, proposed resolutions and Directors´ Compensation Policy for 2020-2022 in relation to item Eight of the Agenda of the General Shareholders´ Meeting of Pharma Mar, S.A. Register number: 2256 Notification modified by communication number 2264 dated 14/05/2020 (20:09) 13/05/2020 17:35 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 6 May and 12 May 2020. Register number: 2223 12/05/2020 09:42 PHARMA MAR, S.A. Board of Directors Regulations La sociedad remite el reglamento del Consejo de Administración Register number: 2172 06/05/2020 17:36 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 29 April and 5 May 2020. Register number: 2067 29/04/2020 17:43 PHARMA MAR, S.A. Share buy-back , stabilisation and treasury stock programmes The company reports the transactions performed in the context of the Share Buy-back Program between 22 April and 28 April 2020. Register number: 1863 29/04/2020 17:39 PHARMA MAR, S.A. Other relevant information The Executive Committee of Pharma Mar, S.A. has decided to implement the Free of Charge Stock Ownership Plan approved by resolution of the General Shareholders’ Meeting of 26 June 2019. Register number: 1861 Page 16 out of 18 «...161718»
